MONTREAL, QUEBEC--(Marketwire - March 28, 2008) - Adaltis Inc. (TSX: ADS), an international in vitro diagnostic (IVD) company, today reported its fourth quarter and year end financial results for 2007 and also articulated its execution plan in order to accelerate its path to create a leading China-based IVD company, targeting China and key emerging markets.
